MRC-Industry Asset Sharing Initiative 2016

Building on the world-leading MRC/AstraZeneca Mechanisms of Disease Call in which 15 high quality experimental medicine grants were awarded, the MRC is now working with 6 industry partners (AstraZeneca, GSK, J&J, Pfizer, Takeda and UCB) to provide researchers access to their deprioritised compounds.

Source: MRC Funding Opportunities - October 6, 2016 Category: Research Source Type: funding